🔎 Trials Near Me

Akèy › Kansè pwostat rezistan a kastasyon › Tennessee › Nashville

Etid klinik pou Kansè pwostat rezistan a kastasyon nan Nashville, TN

3 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Ap rekriteFaz 3
  • Tennessee Oncology Nashville, Nashville
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07164443

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

Ap rekriteFaz 1
  • Tennessee Oncology, Nashville
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07719361

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Ap rekriteFaz 1
  • Sarah Cannon Research, Nashville
Laj 18 a 100 · Gason · Mizajou Aug 13, 2026 · NCT05519449

Etid Kansè pwostat rezistan a kastasyon nan lòt vil

Lòt etid nan Nashville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.